CN Patent

CN103038237A — 用于黄病毒感染治疗或预防的类似物

Assigned to Vertex Pharmaceuticals Inc · Expires 2013-04-10 · 13y expired

What this patent protects

由式I代表的化合物 或其药学上可接受的盐，其中A、B、B’、X、Y、R 1 、R 2 、R 2 ’、R 3 、R 3 ’、R 4 、R 4 ’、R 5 、R 5 ’、m、n或p是如本文所定义的，可用于治疗黄病毒科病毒感染。

USPTO Abstract

由式I代表的化合物 或其药学上可接受的盐，其中A、B、B’、X、Y、R 1 、R 2 、R 2 ’、R 3 、R 3 ’、R 4 、R 4 ’、R 5 、R 5 ’、m、n或p是如本文所定义的，可用于治疗黄病毒科病毒感染。

Drugs covered by this patent

Patent Metadata

Patent number
CN103038237A
Jurisdiction
CN
Classification
—
Expires
2013-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.